AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 2385 businesses audited.
Unclear / Mixed / Unclassifiable Industry BS: Tamiflu (Genentech) (tamiflu.com)
Tamiflu.com is a high-substance, low-bullshit site where content is dictated by regulatory compliance rather than marketing whim. Its low score is a reflection of the legal necessity for precision in the pharmaceutical industry.
Update the clinical and third-party citations to reflect data from the last 36 months to remove ‘stale’ modifiers. Implement structured Person schema for the Chief Medical Officer or relevant scientific leads to strengthen the authority footprint. Convert in-text URL citations into structured proof links to improve verifiable evidence density. Add a ‘Last Updated’ timestamp to the Safety Information blocks to confirm the content is current as of 2026.
Information density is exceptionally high, with headings such as ‘Flu Treatment’ and ‘How to Take Tamiflu’ leading to specific clinical nouns and numbers. Body text includes precise data: a 75 mg dose, twice daily for 5 days, and a 48-hour efficacy window. Fluff is virtually nonexistent, with power words used only in the context of the antiviral’s mechanical claim (‘Attack the flu virus at its source’).
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is zero semantic drift between pages. The homepage H1 ‘Important Safety Information’ and the H3 signal regarding flu treatment are expanded with perfect consistency across ‘Taking Tamiflu’ and ‘Tamiflu for Children.’ The messaging regarding the 48-hour treatment window and the age indications (2 weeks+ for treatment, 1 year+ for prevention) is repeated with legalistic precision.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
The site avoids trust theatre by completely omitting customer reviews (review_count: 0) and avoiding common ‘Five-star’ cliches. However, trust is slightly undermined by stale evidence; the references to Mayo Clinic are dated November 2018, which is 91 months prior to the current June 2026 anchor. While factual, the lack of updated citation dates in nearly 8 years is a signal of content stagnation.
The proof density is high for a product site, citing specific percentages (82% reduction in flu chance) and time-based recovery metrics. There are at least 8 distinct points of specific evidence across the pages, including storage guidelines, dosing by weight, and age-specific indications, resulting in a 0-point penalty for specificity absence.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site lacks common industry cliches like ‘innovative solutions’ or ‘disruptive technology.’ The ‘FAQ’ section is a necessary template fingerprint for pharma, but the content within is non-generic, providing specific instructions for missed doses and storage temperatures (68°F to 77°F). The value proposition is entirely unique to the oseltamivir phosphate molecule.
Authority is firmly established through the Genentech Organization schema. There are no ‘expert’ gurus or influencers claimed; the authority is the pharmaceutical manufacturer and the FDA approval. The only gap is the technical implementation of proof; the system records 0 proof_links_count because citations are provided in text rather than as verifiable outbound metadata links.
The performance claims are modest and clinical rather than hyperbolic. The site claims Tamiflu helps children get better ‘1.5 days (26%) faster,’ which is a specific, measurable result attributed to a study. This is the opposite of the typical ‘results that speak for themselves’ marketing fluff.
Unclear / Mixed / Unclassifiable Industry BS: Tamiflu (Genentech) (tamiflu.com)
The website is a perfect match for the Pharmaceutical/Healthcare category. The content is strictly limited to FDA-approved indications, dosing, and safety information for a specific prescription medication.
When your canonical, redirect, and final URL disagree, the model treats each version as a separate entity. Study the Canonical Integrity Framework Guide and see why stable identity is the prerequisite for AI driven retrieval.
“The score was primarily driven by the 'Trust and Proof' and 'Information Density' pillars. The 11 points reflect minor penalties for stale 2018 citations and the legalistic repetition of safety warnings, which—while necessary—registers as concept repetition in a standard BS audit.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Tamiflu (Genentech) to view the most current version of their content and see directly what the company offers.